Skip to main content
Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · IEX Real-Time Price · USD
11.21
-0.79 (-6.58%)
At close: May 17, 2024, 4:00 PM
10.82
-0.39 (-3.48%)
After-hours: May 17, 2024, 4:26 PM EDT

Cidara Therapeutics Revenue

Cidara Therapeutics had revenue of $46.38M in the twelve months ending March 31, 2024, down -44.42% year-over-year. Revenue in the quarter ending March 31, 2024 was $8.46M, a -67.58% decrease year-over-year. In the year 2023, Cidara Therapeutics had annual revenue of $63.91M, a decrease of -0.84%.

Revenue (ttm)
$46.38M
Revenue Growth
-44.42%
P/S Ratio
1.15
Revenue / Employee
$672,145
Employees
69
Market Cap
53.14M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202363.91M-543.00K-0.84%
Dec 31, 202264.45M14.88M30.01%
Dec 31, 202149.57M37.51M310.81%
Dec 31, 202012.07M-8.85M-42.30%
Dec 31, 201920.92M--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inotiv 552.74M
Rockwell Medical 86.62M
Cytosorbents 36.69M
Aligos Therapeutics 13.79M
Milestone Scientific 9.48M
Dyadic International 2.26M
Revenue Rankings

CDTX News

More News